| Neglected disease research and development: how much are we really spending? M Moran, J Guzman, AL Ropars, A McDonald, N Jameson, B Omune, ... PLoS medicine 6 (2), e1000030, 2009 | 322 | 2009 |
| Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies L Wu, LL van den Hoogen, H Slater, PGT Walker, AC Ghani, CJ Drakeley, ... Nature 528 (7580), S86-S93, 2015 | 264 | 2015 |
| Evaluating the impact of pulse oximetry on childhood pneumonia mortality in resource-poor settings J Floyd, L Wu, D Hay Burgess, R Izadnegahdar, D Mukanga, AC Ghani Nature 528 (7580), S53-S59, 2015 | 115 | 2015 |
| Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections A Barry, J Bradley, W Stone, MW Guelbeogo, K Lanke, A Ouedraogo, ... Nature communications 12 (1), 2443, 2021 | 82 | 2021 |
| Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a … MS Hsiang, H Ntuku, KW Roberts, MSK Dufour, B Whittemore, M Tambo, ... The Lancet 395 (10233), 1361-1373, 2020 | 78 | 2020 |
| Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology L Wu, T Hall, I Ssewanyana, T Oulton, C Patterson, H Vasileva, S Singh, ... Wellcome open research 4, 26, 2020 | 72 | 2020 |
| Neglected Disease Research & Development: A Five Year Review M Moran, J Guzman, K Henderson, L Abela-Oversteegan, R Liyanage, ... Health Policy Division, The George Institute for International Health, 2012 | 51 | 2012 |
| Registering new drugs for low-income countries: the African challenge M Moran, N Strub-Wourgaft, J Guzman, P Boulet, L Wu, B Pecoul PLoS medicine 8 (2), e1000411, 2011 | 51 | 2011 |
| malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication malERA Refresh Consultative Panel on Characterising the Reservoir and ... PLoS medicine 14 (11), e1002452, 2017 | 43 | 2017 |
| Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum … J Achan, IJ Reuling, XZ Yap, E Dabira, A Ahmad, M Cox, D Nwakanma, ... Clinical infectious diseases 70 (12), 2544-2552, 2020 | 41 | 2020 |
| Neglected disease research & development: new times, new trends M Moran, J Guzman, K Henderson, AL Ropars, A McDonald, L McSherry, ... Health Policy Division, The George Institute for International Health, 2009 | 34 | 2009 |
| Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons … L Wu, J Mwesigwa, M Affara, M Bah, S Correa, T Hall, SK Singh, ... BMC medicine 18, 1-17, 2020 | 31 | 2020 |
| Determining seropositivity—a review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases YY Chan, K Fornace, L Wu, BF Arnold, JW Priest, DL Martin, MA Chang, ... PLoS neglected tropical diseases 15 (6), e0009457, 2021 | 30 | 2021 |
| Impact of a rapid decline in malaria transmission on antimalarial IgG subclasses and avidity I Ssewanyana, J Rek, I Rodriguez, L Wu, E Arinaitwe, JI Nankabirwa, ... Frontiers in Immunology 11, 576663, 2021 | 23 | 2021 |
| Neglected disease research and development: Is innovation under threat? M Moran, J Guzman, L Abela-Oversteegen, R Liyanage, B Omune, L Wu, ... (No Title), 2011 | 23 | 2011 |
| Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration L Wu, J Mwesigwa, M Affara, M Bah, S Correa, T Hall, SK Singh, ... BMC medicine 18, 1-14, 2020 | 21 | 2020 |
| Estimating effects of intervention measures on COVID-19 outbreak in Wuhan taking account of improving diagnostic capabilities using a modelling approach J Liang, HY Yuan, L Wu, DU Pfeiffer BMC infectious diseases 21 (1), 424, 2021 | 11 | 2021 |
| Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the … H Ntuku, C Smith-Gueye, V Scott, J Njau, B Whittemore, B Zelman, ... BMJ open 12 (6), e049050, 2022 | 10 | 2022 |
| A framework for evaluating health system surveillance sensitivity to support public health decision-making for malaria elimination: a case study from Indonesia RA Ahmad, L Nelli, H Surendra, RR Arisanti, DAS Lesmanawati, I Byrne, ... BMC infectious diseases 22 (1), 619, 2022 | 9 | 2022 |
| Prioritising the need for new diagnostics, medicine, vaccines and management practices of zoonoses which have significant impact in the developing world R Kock, S Croft, M Dixon, C Fletcher, L Good, J Guzman, D Heymann, ... DfID Zoonoses Studies Report Series 6, 2011-2012, 2012 | 9 | 2012 |
